A cell-bound bacteriocin was extracted from a Bacteroidesfragilis BF-11 strain by treating the cells with a low-molarity buffer (0.01 M Tris-hydrochloride, pH 8.0). Sucrose osmotic shock experiments and ultrasonic lysis of whole cells indicated that the majority of the bacteriocin was located at the cell surface. Culture supernatants contained no significant bacteriocin activity. The bacteriocin was purified by DEAEcellulose and Sephacryl S200 chromatography and had an apparent molecular weight of approximately 7,000. It was relatively heat stable and was inactivated by proteases. There was a delay of approximately 3.5 h before DNA, RNA, and protein synthesis were inhibited by the bacteriocin. Inhibition of macromolecular synthesis coincided with lysis of the susceptible indicator strain.
A cell-bound bacteriocin was extracted from a Bacteroidesfragilis BF-11 strain by treating the cells with a low-molarity buffer (0.01 M Tris-hydrochloride, pH 8.0). Sucrose osmotic shock experiments and ultrasonic lysis of whole cells indicated that the majority of the bacteriocin was located at the cell surface. Culture supernatants contained no significant bacteriocin activity. The bacteriocin was purified by DEAEcellulose and Sephacryl S200 chromatography and had an apparent molecular weight of approximately 7,000. It was relatively heat stable and was inactivated by proteases. There was a delay of approximately 3.5 h before DNA, RNA, and protein synthesis were inhibited by the bacteriocin. Inhibition of macromolecular synthesis coincided with lysis of the susceptible indicator strain.
There are numerous reports on the characterization of bacteriocins produced by aerobic bacteria (7, 9, 11, 22) , but the bacteriocins produced by strains of the anaerobic genus Bacteroides have not been extensively studied. Booth et al. (1) have investigated the production of a high-molecularweight bacteriocin (>300,000) by a Bacteroides strain and the role of this strain in the ecology of the colon. Mossie et al. (12) purified a lower-molecular-weight bacteriocin (about 16 ,000) from a Bacteroides fragilis Bf-1 strain and reported that it inhibited RNA synthesis. Nakamura et al. (15) studied a cell-bound bacteriocin-like protein (melaninocin) which had an apparent molecular weight of about 105,000 and was produced by Bacteroides melaninogenicus.
Since the production of more than one bacteriocin by a single bacterial strain is not uncommon (22) , we investigated the production of a cell-bound bacteriocin by a derivative of the B. fragilis Bf-1 strain Bf-11 which had lost the ability to produce the cell-free bacteriocin described by Mossie et al. (12) .
MATERIALS AND METHODS
Bacterial strains. A derivative of B. fragilis Bf-1 (designated Bf-11) which had lost the ability to produce the cell-free bacteriocin which was studied by Mossie et al. (12) (13) (14) was used for the production of the bacteriocin. The susceptible indicator strain (Bf-2) and the 10 rifampin-resistant Bf-2 mutants have been described previously (13) .
Media and bacteriocin assay. The bacteriocin was produced in a complex medium which contained, in grams per liter, Difco tryptic soy broth, 24; Difco yeast extract, 10; glucose, 1; and L-cysteine-hydrochloride 0.5. The bacteriocin was assayed with porcelain beads (18) containing 20-,ul samples which were placed on the surface of a 3-ml seeded soft agar overlay on brain heart infusion agar plates which contained, in grams per liter, Difco brain heart infusion, 37; Difco yeast extract, 5; L-cysteine-hydrochloride, 0.5; and agar, 15. Bacteriocin titers in arbitrary units (AU) were expressed as the reciprocal of the highest doubling dilution that gave a zone of inhibition surrounding the bead. The minimal medium of Varel and Bryant (23) (2) .
Bacteriocin purification. Overnight cultures (100 ml) of B. fragilis Bf-11 were harvested by centrifugation, and the cells were suspended in 10 ml of extraction buffer (0.01 M Trishydrochloride, pH 8.0) for 30 min at 20°C. The bacteriocin was also extracted by the sucrose osmotic shock method of Willis et al. (24) . The cells were disrupted by ultrasonication (Heat Systems-Ultrasonics Inc.) at 4°C. All subsequent operations were performed at 4°C. The supernatant obtained after centrifugation was dialyzed in dialysis tubing with a molecular cutoff of 6,000 to 8,000 against distilled water for 16 h. The molecular weight of the bacteriocin was determined by Sephacryl S200 chromatography (two 10-by-400-mm columns connected in series) and sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). The column was calibrated with cytochrome c (12,400 molecular weight), ovalbumin (45,000 molecular weight), and Transferrin (90,000 molecular weight). Discontinuous SDS-PAGE was carried out by the methods described by Laemmli (10) and O'Farrell (17) , and 10 to 20% polyacrylamide gradient gels gave the best resolution of the bacteriocin.
Bacteriocin stability. The effect of pH on the stability of the purified bacteriocin was determined in 0.1 M citrate-phosphate-borate-hydrochloride buffer (3) . A purified bacteriocin preparation was dialyzed against distilled water, and 10 ,ul was added to 90 ,ul of the various pH buffers in steps of 1 pH unit from pH 3 to 10. After 4 h at 8 to 10°C, the samples were assayed for residual activity. The susceptibility of the bacteriocin to proteolytic enzymes was tested by incubation of a purified preparation of bacteriocin with protease from Streptomyces griseus (Sigma) at a concentration of 1 mg/ml (pH 7.6) at 37°C for 30 min. Trypsin (Difco, 1:250), DNase and RNase (Miles Laboratories, Inc.) were also tested under the same conditions. After incubation, the mixtures were heated at 65°C for 20 min to reduce any possible interference by the enzymes in the assay of the bacteriocin.
This heat treatment reduced the activity of the S. griseus protease by 50% and trypsin by 90%o. The sensitivity of B. fragilis Bf-2 cells to the bacteriocin was not affected by pretreatment with 0.5 mg of the proteases per ml for 10 min, followed by washing in growth medium. Synthesis of proteins and nucleic acids. Syntheses of DNA, RNA, and protein by the indicator strain (Bf-2) in the presence of bacteriocin were determined under stringent anaerobic conditions by the incorporation of [2-14C]thymidine (5 ,ug/ml, 3 ,uCi/ml), [3H]uracdil (20 jig/ml, 15 ,uCi/ml), and [35S]methionine (25 pg/ml, 20 ,uCi/ml), respectively, into cold trichloroacetic acid-precipitable material. Exponentialphase cells were labeled for 30 min before the addition of purified bacteriocin (8 AU/ml).
RNA polymerase assay. RNA polymerase was purified from the B. fragilis Bf-2 indicator strain by the method of Davison (4) . The RNA polymerase assay has been described previously (19) .
RESULTS
Bacteriocin purification. Culture supernatants of B. fragilis Bf-11 contained very low levels of bacteriocin activity. Relatively high levels of bacteriocin activity were obtained after treatment of B. fragilis Bf-11 with the low-molarity buffer ( Table 1) . The bacteriocin was eluted from DEAEcellulose by a 0.01 to 0.2 M KCl gradient and was purified further by Sephacryl S200 chromatography. SDS-PAGE of the purified active preparation revealed a single protein band ( Fig. 1 and 2) .
Since SDS interfered with the bacteriocin assay, the activity of the single band after SDS-PAGE could not be determined. PAGE of an undenatured sample of the bacteriocin on a 5 to 15% polyacrylamide gradient (pH 8.25) was carried out. Under these conditions, the bacteriocin was not resolved as well as on SDS-PAGE, and a broad band which was shown to have bacteriocin activity was obtained.
A 36-fold purification was achieved after Sephacryl S200 chromatography (Table 1 and Fig. 2 ). The bacteriocin was totally retained by dialysis tubing with a molecular cutoff of 6,000 to 8,000 and was not detected in the dialysate after 16 h of dialysis. However, it was not retained by dialysis tubing with a 12,000 to 14,000 molecular weight cutoff and was estimated to have a molecular weight of 7,200 or 6,400 by Sephacryl S200 chromatography and SDS-PAGE, respectively. Bacteriocin activity was not obtained in highermolecular-weight fractions after Sephacryl S200 chromatography (Fig. 3) . Cellular localization of the bacteriocin. Culture supernatants of B. fragilis Bf-11 contained very low levels of bacteriocin ( Table 1 ). The majority of the bacteriocin was released from the cells either by treatment with the lowmolarity buffer or by sucrose osmotic shock ( did not release the bacteriocin, and the appropriate bacteriocin band was not present after SDS-PAGE (Fig. 1, lane c) . Extraction with the low-molarity buffer resulted in a higher specific activity of the bacteriocin than extraction by sucrose osmotic shock, which released more contaminating nonbacteriocin proteins (Table 1 and Fig. 1) . Examination of the cells by phase-contrast microscopy indicated that they were not lysed or disintegrated by these extraction procedures. This is also shown by the difference in the protein profiles between the extracts and the extracted cells after ultrasonication (Fig. 1, lanes f and h) .
Ultrasonicated cell preparations did not result in an increased yield of bacteriocin (Table 1) . Although ultrasonication disrupted the cells, it did not inactivate the bacteriocin.
Bacteriocin stability. The optimum pH for the stability of the purified bacteriocin was between pH 6 and 9. There was a marked reduction in activity above pH 9 and some reduction in activity below pH 6. The bacteriocin was stable at 50 and 60°C for 5 and 3 h, respectively. At 70°C, there was an initial 50% loss in activity after 1 h but no further loss in activity over 4 h. After autoclaving at 121°C for 15 min, 25% of the initial activity was retained.
The bacteriocin was inactivated 85% by S. griseus protease but only 30% by trypsin at a similar concentration. DNase and RNase did not have any affect on activity. Untreated bacteriocin retained its titer after the heat treatment used to reduce the activity of the enzymes.
Specificity of the bacteriocin. The bacteriocin susceptibility of 31 B. fragilis isolates from different clinical samples was determined. These isolates had been characterized as different from each other on the basis of phage susceptibility, bacteriocin production, and bacteriocin susceptibility. Of these isolates, eight were susceptible to the bacteriocin. B. fragilis ATCC 29771 was resistant to the bacteriocin. The bacteriocin did not affect isolates of Escherichia coli or of Klebsiella, Acinetobacter, Pseudomonas, and Staphylococcus species.
Since B. fragilis Bf-11 was a derivative of B. fragilis Bf-1, which was shown by Mossie et al. (12) (13) (14) to produce an extracellular low-molecular-weight bacteriocin which inhibited RNA polymerase activity, it was important to establish that the cell-bound bacteriocin was a different bacteriocin. Mossie et al. (13) isolated 10 rifampin-resistant B. fragilis Bf-2 mutants from the indicator strain which were shown to be resistant to the bacteriocin described by Mossie et al. (12) . These rifampin-resistant mutants were susceptible to the cell-bound bacteriocin, which did not inhibit B. fragilis RNA polymerase in the in vitro RNA polymerase assay.
Nucleic acid and protein synthesis. There was a delay of approximately 3.5 h before DNA, RNA, and protein synthesis was inhibited at about the same time, and the inhibition of macromolecular synthesis coincided with a decrease in turbidity of the cultures (Fig. 4) .
DISCUSSION
The low-molecular-weight bacteriocin we have described was extracted by suspending the cells in low-molarity buffer and by osmotic shocking. These treatments did not lyse the cells, and it is concluded that the bacteriocin is cell-bound.
The inhibitor we have described can be considered to be a bacteriocin since it is a bactericidal protein with a narrow activity spectrum and is inactive against the producer strain (9, 22). The B. fragilis bacteriocin differs from most other 16,000 (12) . The 16,000-molecular-weight bacteriocin inhibited RNA polymerase activity. Although the 7,000-molecular-weight bacteriocin is produced by a derivative of the strain which produced the 16,000-molecular-weight bacteriocin, it is a different bacteriocin. The 16,000-molecular-weight bacteriocin was detected in culture supernatants and inhibited RNA synthesis immediately. DNA, RNA, and protein synthesis were inhibited simultaneously by the 7,000-molecular-weight bacteriocin after a 3.5-h delay. Furthermore, this bacteriocin was active against B. fragilis Bf-2 rifampin-resistant mutants which were isolated from the Bf-2 indicator strain and were resistant to the 16,000-molecular-weight bacteriocin. The B. fragilis bacteriocin described by Booth et al. (1) is completely different in that it is very large, with a molecular weight of 300,000. The 7,000-molecular-weight B. fragilis bacteriocin resembles melaninocin from B. melaninogenicus in that both bacteriocins were not detected in culture supernatant and had to be extracted from the cells (15) . Other low-molecular-weight bacteriocins which have been reported are colicin V (4,000 molecular weight) and a bacteriocin (5,000 molecular weight) from Staphylococcus aureus (6, 16) .
Although the mode of action of the 7,000-molecularweight bacteriocin has not been identified, the long delay between the addition of the bacteriocin to susceptible cells and the inhibition of macromolecular synthesis indicates that the mode of action differs from that of most bacteriocins, which affect some aspect of cell metabolism relatively rapidly (within 10 min) (9) . Inhibition of macromolecular synthesis by the B. fragilis bacteriocin coincides with a decrease in turbidity, and it is suggested that the bacteriocin may be a lytic agent. Pesticin acts as a lysozyme and has a protracted effect on susceptible cells before causing lysis and the inhibition of macromolecular synthesis (5, 8) . Colicin M, which also induces lysis of susceptible cells (20) , has been shown to be an inhibitor of murein biosynthesis (21) . 
